Cabintoy, Maricel L.
HRN: 26-64-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
CEFUROXIME 1.5GM (VIAL)
02/07/2025
02/14/2025
IV
1.5 G
Q8HRS
ACUTE PYELONEPHRITIS
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: No